West Announces Second-Quarter 2020 Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. RNG
2. WDC
3. DECK
4. BYD
5. WCN
6. SPOT
7. FIX
8. TSCO
9. BE
10. SLM

Go back to West Announces Second-Quarter 2020 Results

West Pharma (WST) Tops Q2 EPS by 34c, Revenues Beat; Raises FY20 EPS/Revenue Guidance Above Consensus

July 23, 2020 6:15 AM EDT

West Pharma (NYSE: WST) reported Q2 EPS of $1.25, $0.34 better than the analyst estimate of $0.91. Revenue for the quarter came in at $527.2 million versus the consensus estimate of $496.09 million.

Second-Quarter 2020 Summary (comparisons to prior-year period)

Net sales of $527.2 million grew 12.2%; organic sales growth was 14.3%.Reported-diluted EPS of $1.21 increased 38%.Adjusted-diluted EPS of $1.25 increased 40%.Company is raising full-year 2020 net sales guidance to a new range of between $2.035 billion and $2.055 billion.Company is raising full-year 2020 adjusted-diluted EPS guidance to a new range of between $4.15 and $4.25.

"Adjusted-diluted EPS"... More